{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:16:15Z","timestamp":1788066975491,"version":"build-2784847793"},"reference-count":38,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Canadian Cancer Society","award":["#707153"],"award-info":[{"award-number":["#707153"]}]},{"award":["#707153"],"award-info":[{"award-number":["#707153"]}],"id":[{"id":"https:\/\/ror.org\/017343w90","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Fonds de Recherche du Qu\u00e9bec en Sant\u00e9","award":["#312831"],"award-info":[{"award-number":["#312831"]}]},{"name":"Fonds de Recherche du Qu\u00e9bec en Sant\u00e9","award":["#330312"],"award-info":[{"award-number":["#330312"]}]},{"award":["#312831"],"award-info":[{"award-number":["#312831"]}],"id":[{"id":"https:\/\/ror.org\/00w3qhf76","id-type":"ROR","asserted-by":"publisher"}]},{"award":["#330312"],"award-info":[{"award-number":["#330312"]}],"id":[{"id":"https:\/\/ror.org\/00w3qhf76","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Background: Circulating tumor DNA (ctDNA) has emerged as a clinically valuable biomarker for cancer detection, treatment monitoring, and minimal residual disease assessment. Despite its growing clinical utility, the biological mechanisms governing ctDNA release remain incompletely understood. The objective of this study was to investigate how chemotherapy-induced cytotoxicity and chemoresistance influence the kinetics and fragmentation patterns of cfDNA released by cancer cells in vitro. Methods: Human lung adenocarcinoma (A549) and esophageal adenocarcinoma (FLO-1, OE19) cell lines were used to investigate cell-free DNA (cfDNA) release and fragmentation in vitro. Cancer cells were treated with chemotherapy (cisplatin and 5-fluorouracil), and cfDNA released into the culture medium was quantified as total cfDNA by Qubit fluorometry and mutation-specific cfDNA by droplet digital PCR (ddPCR). A cisplatin-resistant OE19 model was generated to directly compare cfDNA release kinetics between chemosensitive and chemoresistant cells. Fragment size distributions were determined and evaluated alongside cell death mechanisms assessed by flow cytometry. Results: cfDNA release correlated positively with viable tumor cell number across all cell lines. Chemotherapy increased per-cell cfDNA release in all cell lines. Chemosensitive OE19 cells exhibited significantly higher cfDNA release compared to chemoresistant OE19 cells following cisplatin exposure, with distinct temporal release kinetics. Additionally, chemotherapy treatment induced a shift toward the release of larger DNA fragments in both chemosensitive and resistant cells. This was accompanied by changes in PI-positive and Annexin V\/PI double-positive cell populations, suggesting altered cell death processes following cisplatin treatment. Conclusions: Chemotherapy-induced cytotoxicity significantly influences cfDNA release kinetics and fragmentation patterns, with distinct effects in chemosensitive and chemoresistant cancer cells. These findings provide mechanistic insight into tumor-derived DNA release biology and may have important implications for the interpretation, timing, and standardization of liquid biopsy testing during treatment. Furthermore, they establish in vitro cancer models as a valuable platform for studying cfDNA dynamics and informing preclinical therapeutic development.<\/jats:p>","DOI":"10.3390\/cells15171561","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:33:52Z","timestamp":1787942032000},"page":"1561","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cell-Free DNA Release Kinetics and Fragmentation Reflect Treatment Response and Resistance In Vitro"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4312-5394","authenticated-orcid":false,"given":"Alexandra","family":"Bartolomucci","sequence":"first","affiliation":[{"name":"Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada"},{"name":"Department of Pathology, McGill University, Montreal, QC H3A 2B4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Laura","family":"Kienzle","sequence":"additional","affiliation":[{"name":"Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4970-0799","authenticated-orcid":false,"given":"Sarah Tadhg","family":"Ferrier","sequence":"additional","affiliation":[{"name":"Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada"},{"name":"Department of Pathology, McGill University, Montreal, QC H3A 2B4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Benjamin","family":"Forgie","sequence":"additional","affiliation":[{"name":"Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada"},{"name":"Department of Pathology, McGill University, Montreal, QC H3A 2B4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"given":"Thupten","family":"Tsering","sequence":"additional","affiliation":[{"name":"Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada"},{"name":"Department of Pathology, McGill University, Montreal, QC H3A 2B4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2245-8640","authenticated-orcid":false,"given":"Kyle","family":"Dickinson","sequence":"additional","affiliation":[{"name":"Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3275-2584","authenticated-orcid":false,"given":"Lorenzo","family":"Ferri","sequence":"additional","affiliation":[{"name":"Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada"},{"name":"Division of Thoracic Surgery, McGill University Health Centre, Montreal, QC H4A 3J1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"given":"Jonathan","family":"Cools-Lartigue","sequence":"additional","affiliation":[{"name":"Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada"},{"name":"Division of Thoracic Surgery, McGill University Health Centre, Montreal, QC H4A 3J1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Julia V.","family":"Burnier","sequence":"additional","affiliation":[{"name":"Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada"},{"name":"Department of Pathology, McGill University, Montreal, QC H3A 2B4, Canada"},{"name":"Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H4A 3T2, Canada"},{"name":"Goodman Cancer Institute, McGill University, Montreal, QC H3A 1A3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41698-025-00876-y","article-title":"Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology","volume":"9","author":"Bartolomucci","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"100926","DOI":"10.1016\/j.medj.2025.100926","article-title":"The comings and goings of cell-free DNA: Biological and clinical implications","volume":"7","author":"Malki","year":"2026","journal-title":"Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"107830","DOI":"10.1016\/j.celrep.2020.107830","article-title":"Senescence, Necrosis, and Apoptosis Govern Circulating Cell-free DNA Release Kinetics","volume":"31","author":"Rostami","year":"2020","journal-title":"Cell Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1158\/1078-0432.CCR-16-0613","article-title":"Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma","volume":"22","author":"Xi","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1158\/1078-0432.CCR-17-0454","article-title":"Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine","volume":"23","author":"Husain","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_6","first-page":"100682","article-title":"Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC","volume":"43","author":"MacManus","year":"2023","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.ccell.2025.09.006","article-title":"Cell-free DNA fragmentomics in cancer","volume":"43","author":"Tsui","year":"2025","journal-title":"Cancer Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1158\/2159-8290.CD-19-0622","article-title":"Plasma DNA End-Motif Profiling as a Fragmentomic Marker in Cancer, Pregnancy, and Transplantation","volume":"10","author":"Jiang","year":"2020","journal-title":"Cancer Discov."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s43018-026-01116-3","article-title":"A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection","volume":"7","author":"Zeng","year":"2026","journal-title":"Nat. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"eaat4921","DOI":"10.1126\/scitranslmed.aat4921","article-title":"Enhanced detection of circulating tumor DNA by fragment size analysis","volume":"10","author":"Mouliere","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","article-title":"Genome-wide cell-free DNA fragmentation in patients with cancer","volume":"570","author":"Cristiano","year":"2019","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"14904","DOI":"10.3748\/wjg.v20.i40.14904","article-title":"MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines","volume":"20","author":"Hummel","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7171\/jbt.18-2902-002","article-title":"The Cellosaurus, a Cell-Line Knowledge Resource","volume":"29","author":"Bairoch","year":"2018","journal-title":"J. Biomol. Tech."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ungerer, V., Bronkhorst, A.J., Uhlig, C., and Holdenrieder, S. (2022). Cell-Free DNA Fragmentation Patterns in a Cancer Cell Line. Diagnostics, 12.","DOI":"10.3390\/diagnostics12081896"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100242","DOI":"10.1016\/j.xgen.2022.100242","article-title":"Circulating DNA fragmentomics and cancer screening","volume":"3","author":"Thierry","year":"2023","journal-title":"Cell Genom."},{"key":"ref_16","first-page":"1659","article-title":"DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells","volume":"61","author":"Jahr","year":"2001","journal-title":"Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/ijc.32586","article-title":"Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma","volume":"146","author":"Strijker","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"McEvoy, A.C., Warburton, L., Al-Ogaili, Z., Celliers, L., Calapre, L., Pereira, M.R., Khattak, M.A., Meniawy, T.M., Millward, M., and Ziman, M. (2018). Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4637-6"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1667\/RR15016.1","article-title":"In Vitro Cell-free DNA Quantification: A Novel Method to Accurately Quantify Cell Survival after Irradiation","volume":"190","author":"Deig","year":"2018","journal-title":"Radiat. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13046-021-01984-w","article-title":"Circulating tumor DNA tracking through driver mutations as a liquid biopsy-based biomarker for uveal melanoma","volume":"40","author":"Bustamante","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Forgie, B.N., Prakash, R., and Telleria, C.M. (2022). Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives. Int. J. Mol. Sci., 23.","DOI":"10.20944\/preprints202211.0271.v1"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: Mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_23","first-page":"2351","article-title":"Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma","volume":"60","author":"Lo","year":"2000","journal-title":"Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Li, A., Lou, E., Leder, K., and Foo, J. (2024). Early ctDNA kinetics as a dynamic biomarker of cancer treatment response. BioRxiv.","DOI":"10.1101\/2024.07.01.601508"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"eabi8618","DOI":"10.1126\/sciadv.abi8618","article-title":"Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges","volume":"8","author":"Zhao","year":"2022","journal-title":"Sci. Adv."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1158\/1078-0432.CCR-22-0741","article-title":"Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI\u2013Treated Patients with EGFR-Mutant NSCLC (SWOG S1403)","volume":"28","author":"Mack","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_27","first-page":"e2400216","article-title":"Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer","volume":"8","author":"Hui","year":"2024","journal-title":"JCO Precis. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1186\/s12967-025-06593-1","article-title":"Patient-derived esophageal adenocarcinoma organ chip: A physiologically relevant platform for functional precision oncology","volume":"23","author":"Pal","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1016\/j.apsb.2026.03.013","article-title":"Organoids, organ-on-a-chip, and microtumors: Biomimetic 3D tumor models advancing drug development and precision medicine","volume":"16","author":"Xia","year":"2026","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e137809","DOI":"10.1172\/jci.insight.137809","article-title":"Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology","volume":"5","author":"Dantes","year":"2020","journal-title":"JCI Insight"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s40246-023-00533-0","article-title":"Multidimensional fragmentomic profiling of cell-free DNA released from patient-derived organoids","volume":"17","author":"Kim","year":"2023","journal-title":"Hum. Genom."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"116097","DOI":"10.1016\/j.ejca.2025.116097","article-title":"Characterization of the cell-free DNA released by tumor organoids derived from colorectal cancer patients","volume":"231","author":"Mirandola","year":"2025","journal-title":"Eur. J. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e83532","DOI":"10.7554\/eLife.83532","article-title":"Cell-free DNA as a potential biomarker of differentiation and toxicity in cardiac organoids","volume":"12","author":"Silver","year":"2023","journal-title":"eLife"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41571-022-00660-y","article-title":"Circulating tumour DNA\u2014Looking beyond the blood","volume":"19","author":"Tivey","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jmoldx.2024.01.008","article-title":"Extraction of Cell-Free DNA: Evaluation of Efficiency, Quantity, and Quality","volume":"26","author":"Terp","year":"2024","journal-title":"J. Mol. Diagn."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e01061-18","DOI":"10.1128\/JCM.01061-18","article-title":"Does Size Matter? Comparison of Extraction Yields for Different-Sized DNA Fragments by Seven Different Routine and Four New Circulating Cell-Free Extraction Methods","volume":"56","author":"Cook","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_37","first-page":"e2200509","article-title":"Tumor-Na\u00efve Circulating Tumor DNA as an Early Response Biomarker for Patients Treated With Immunotherapy in Early Phase Clinical Trials","volume":"7","author":"Genta","year":"2023","journal-title":"JCO Precis. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/2643-3230.BCD-21-0029","article-title":"Circulating Tumor DNA in Lymphoma: Principles and Future Directions","volume":"3","author":"Roschewski","year":"2022","journal-title":"Blood Cancer Discov."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/17\/1561\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T04:26:49Z","timestamp":1788064009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/17\/1561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":38,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cells15171561"],"URL":"https:\/\/doi.org\/10.3390\/cells15171561","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]}}}